Effects of doxycycline on the development of bone damage caused by prednisolone in rats

Polish Journal of Pharmacology

Volumn 51, Issue 3, 1999, Pages 243-251

  Folwarczna, Joanna ^a   Janiec, Waldemar ^a   Firlus, Katarzyna ^a   Kaczmarczyk Sedlak, Ilona ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bone; Doxycycline; Osteopenia; Prednisolone

Indexed keywords

CALCIUM; DOXYCYCLINE; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE INJURY; BONE MARROW; BONE MASS; BONE MINERAL; CONTROLLED STUDY; DIAPHYSIS; DRUG EFFECT; EPIPHYSEAL CARTILAGE; FEMUR; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOID; OSTEOLYSIS; OSTEOPENIA; PERIOSTEUM; RAT; TIBIA; TRABECULAR BONE;

ADMINISTRATION, ORAL; ANIMALS; BONE DISEASES, METABOLIC; DOXYCYCLINE; GLUCOCORTICOIDS; MALE; PREDNISOLONE; RATS; TIME FACTORS;

EID: 0033027457     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Aoyagi M., Sasaki T., Ramamurthy N. S., Golub L. M.: Tetracycline/flurbiprofen combination therapy modulates bone remodeling in ovariectomized rats: preliminary observations. Bone, 1996, 19, 629-635.
2. Engesaeter L. B., Skar A. G.: Effects of cloxacillin, doxycycline, fusidic acid and lincomycin on the mechanical properties of bone and skin in young rats. Acta Orthop. Scand., 1979, 50, 245-249.
3. Engesaeter L. B., Underdal T., Langeland N.: Effects of oxytetracycline on mineralization of bone in young rats. Acta Orthop. Scand., 1980, 51, 459-465.
4. Engesaeter L. B., Underdal T., Lyngaas K. H. N.: Effects of cloxacillin, doxycycline, fusidic acid and lincomycin on mineralization and solubility of collagen in young rats. Acta Orthop. Scand., 1980, 51, 467-470.
5. Golub L. M., Ramamurthy N. S., Kaneko H., Sasaki T., Rifkin B., McNamara T. F.: Tetracycline administration prevents diabetes-induced osteopenia in the rat: initial observations. Res. Commun. Chem. Pathol. Pharmacol., 1990, 68, 27-40.
6. Golub L. M., Suomalainen K., Sorsa T.: Host modulation with tetracyclines and their chemically modified analogues. Curr. Opin. Dent., 1992, 2, 80-90.
7. Gomes B. C., Golub L. M., Ramamurthy N. S.: Tetracyclines inhibit parathyroid hormone-induced bone resorption in organ culture. Experientia, 1984, 40, 1273-1275.
8. Greenwald R. A., Simonson B. G., Moak S. A., Rush S. W., Ramamurthy N. S., Laskin R. S., Golub L. M.: Inhibition of epiphyseal cartilage collagenase by tetracyclines in low phosphate rickets in rats. J. Orthop. Res., 1988, 6, 695-703.
9. Grevstad H. J., Bøe O. E.: Effect of doxycycline on surgically induced osteoclast recruitment in the rat. Eur. J. Oral Sci., 1995, 103, 156-159.
10. Ingman T., Sorsa T., Suomailainen K., Halinen S., Lindy O., Lauhio A., Saari H., Konttinen Y. T., Golub L. M.: Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J. Periodontol., 1993, 64, 82-88.
11. Jones G., Sambrook P. N.: Drug-induced disorders of bone metabolism. Incidence, management and avoidance. Drug Safety, 1994, 10, 480-489.
12. Klapisz-Wolikow M., Saffar J. L.: Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat. J. Cell. Physiol., 1996, 167, 359-368.
13. Levy J., Omoy A., Atkin I.: Influence of tetracycline on the calcification of epiphyseal rat cartilage. Transmission and scanning electron-microscopic studies. Acta Anat., 1980, 106, 360-369.
14. Rifkin B. R., Vernillo A. T., Golub L. M.: Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically modified analogs. J. Periodontol., 1993, 64, 819-827.
15. Rifkin B. R., Vernillo A. T., Golub L. M., Ramamurthy N. S.: Modulation of bone resorption by tetracyclines. Ann. N. Y. Acad. Sci., 1994, 732, 165-180.
16. Sasaki T., Kaneko H., Ramamurthy N. S., Golub L. M.: Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat. Rec., 1991, 231, 25-34.
17. Seymour R. A., Heasman P. A.: Tetracyclines in the management of periodontal diseases. A review. J. Clin. Periodontol., 1995, 22, 22-35.
18. Simmons D. J., Chang S.-L., Russell J. E., Grazman B., Webster D., Oloff C.: The effect of protracted tetracycline treatment on bone growth and maturation. Clin. Orthop., 1983, 180, 253-259.
19. van der Bijl P., Pitigoi-Aron G.: Tetracyclines and calcified tissues. Ann. Dent., 1995, 54, 69-72.
20. Williams S., Wakisaka A., Zeng Q. Q., Barnes J., Martin G., Wechter W. J., Liang C. T.: Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone, 1996, 19, 637-644.
21. Wolinsky-Friedland M.: Drug-induced metabolic bone disease. Endocrinol. Metabol. Clin. N. Amer., 1995, 24, 395-420.